Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial-Reference-Cited by-同舟云学术

Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial

Published:2016-05-19 Issue:05 Volume:76 Page:542-550
ISSN:0016-5751
Container-title:Geburtshilfe und Frauenheilkunde
language:de
Short-container-title:Geburtshilfe Frauenheilkd

Author:

Schröder L.¹,Rack B.¹,Sommer H.¹,Koch J.¹,Weissenbacher T.¹,Janni W.²,Schneeweiss A.³,Rezai M.⁴,Lorenz R.⁵,Jäger B.⁶,Schramm A.²,Häberle L.⁷,Fasching P.⁷,Friedl T.²,Beckmann M.⁷,Scholz C.²

Affiliation:

1. Department of Gynecology and Obstetrics, Ludwig-Maximilians-University, Munich

2. Department of Gynecology and Obstetrics, University of Ulm, Ulm

3. Head of Division Gynecologic Oncology National Center for Tumor Diseases, Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg

4. Luisenkrankenhaus Düsseldorf, Düsseldorf

5. Gemeinschaftspraxis Dr. R. Lorenz/N. Hecker, Braunschweig

6. Department of Gynecology and Obstetrics, Heinrich Heine University of Düsseldorf, Düsseldorf

7. Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen

Publisher

Georg Thieme Verlag KG

Subject

Maternity and Midwifery,Obstetrics and Gynecology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0042-106209.pdf

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-07-09

2. Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial;Breast Cancer Research;2020-10-23

3. VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment;Scientific Reports;2020-02-27

4. Drug Combinations in Breast Cancer Therapy;Pharmaceutical Nanotechnology;2019-05-10

5. Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study;The Breast;2019-04